Mabwell (Shanghai) Bioscience Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Mabwell (Shanghai) Bioscience Co., Ltd.

Why is Mabwell (Shanghai) Bioscience Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 0%

The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 100.64% and Operating profit at -18.67% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has reported losses. Due to this company has reported negative ROE

Poor long term growth as Net Sales has grown by an annual rate of 100.64% and Operating profit at -18.67% over the last 5 years

The company has declared Negative results for the last 4 consecutive quarters

INTEREST(HY) At CNY 37.4 MM has Grown at 121.62%
ROCE(HY) Lowest at -61.35%
DEBT-EQUITY RATIO (HY) Highest at 97.71 %

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 71.00%, its profits have fallen by -6.2%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Mabwell (Shanghai) Bioscience Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Mabwell (Shanghai) Bioscience Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Mabwell (Shanghai) Bioscience Co., Ltd.

60.65%

0.38

76.66%

China Shanghai Composite

12.36%

0.86

14.45%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

100.64%

EBIT Growth (5y)

-18.67%

EBIT to Interest (avg)

-92.39

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.87

Sales to Capital Employed (avg)

0.04

Tax Ratio

0.08%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

12.40

EV to EBIT

-9.91

EV to EBITDA

-11.86

EV to Capital Employed

6.11

EV to Sales

63.24

PEG Ratio

Dividend Yield

ROCE (Latest)

-61.68%

ROE (Latest)

-140.93%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

NET SALES(9M)

At CNY 122.8 MM has Grown at 19.94%

NET PROFIT(HY)

Higher at CNY -641.86 MM

RAW MATERIAL COST(Y)

Fallen by -67.28% (YoY

-15What is not working for the Company

INTEREST(HY)

At CNY 37.4 MM has Grown at 121.62%

ROCE(HY)

Lowest at -61.35%

DEBT-EQUITY RATIO (HY)

Highest at 97.71 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.75%

NET SALES(Q)

At CNY 43.11 MM has Fallen at -10.98%

Here's what is working for Mabwell (Shanghai) Bioscience Co., Ltd.

Net Profit

Higher at CNY -641.86 MM

than preceding 12 month period ended Mar 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Raw Material Cost

Fallen by -67.28% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Mabwell (Shanghai) Bioscience Co., Ltd.

Interest

At CNY 37.4 MM has Grown at 121.62%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at 97.71 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 0.75% and Fallen

In each half year in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Net Sales

At CNY 43.11 MM has Fallen at -10.98%

over average net sales of the previous four periods of CNY 48.43 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)